About Medilux Laboratories Pvt Ltd
Data last updated:
Medilux Laboratories Pvt Ltd is a private limited company based in Indore, Madhya Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 April 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1985PTC002843. Its GSTIN is 23AABCM1739L1ZI (Madhya Pradesh).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.5 Cr. It is led by directors including Deepak Kanhiyalal Kewalramani (Managing Director) and Sanjay Kanhiyalal Kewalramani.
Its last annual general meeting (AGM) was held on 29 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at 201. B.C Chamber 47 – Jaora Compound, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2018, the company reported a revenue of ₹89.42 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹7.71 Cr (net margin 8.6%) and EBITDA of ₹19.51 Cr (EBITDA margin 21.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.
The company has about 373 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Medilux. As per MCA filings, the company has open charges of ₹55.98 Cr and satisfied charges of ₹2.26 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 2 cases are pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹6.44 Cr; the latest was in February 2009. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Agog Pharma Limited with revenue of ₹89.88 Cr.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website medilux.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address201. B.C Chamber 47 – Jaora Compound, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medilux Laboratories Pvt Ltd
The main business activity of Medilux Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medilux Laboratories Pvt Ltd FY 2016 filings available
Medilux Laboratories Pvt Ltd reported revenue of ₹89.42 Cr (down 2% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Medilux Laboratories Pvt Ltd
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medilux Laboratories Pvt Ltd
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | ₹89.42 Cr | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹19.51 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.71 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medilux Laboratories Pvt Ltd
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 21.8% | •••• | •••• | •••• |
| Net Profit Margin | 8.6% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medilux Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agog Pharma Limited | ₹89.88 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Alcedo Pharmachem Private Limited | ₹89.55 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Hyderabad, Telangana, India |
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | •••• | •••• | 263.0% | •••• | New Delhi, Delhi, India |
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Andhra Pradesh, India |
| Sam Fine O Chem Limited | ₹89.46 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Rajkot, Gujarat, India |
| Medilux Laboratories Pvt Ltd this company | ₹89.42 Cr (FY 2018) | •••• | •••• | -2.0% | •••• | Indore, Madhya Pradesh, India |
| Ferring Therapeutics Private Limited | ₹89.33 Cr (FY 2021) | •••• | •••• | -3.0% | •••• | Thane, Maharashtra, India |
| Evertogen Life Sciences Limited | ₹89.28 Cr (FY 2024) | •••• | •••• | 51.0% | •••• | Hyderabad, Telangana, India |
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | •••• | •••• | 421.0% | •••• | Mumbai, Maharashtra, India |
| Tagoor Chemicals Private Limited | ₹88.93 Cr (FY 2021) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Gnosis Pharmaceuticals Private Limited | ₹88.76 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Medilux Laboratories by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd is audited by MANTRI RANJAN & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANTRI RANJAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medilux Laboratories Pvt Ltd
Medilux Laboratories has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kanhiyalal Kewalramani Also directs: Medilux Pharma LLP, Deepaksan Tradex LLP, Urbasy (India) Apparels Private Limited and 5 more | Director | 25 May 2011 | 15 Years 4 Months | Current |
| Deepak Kanhiyalal Kewalramani Also directs: Medilux Pharma LLP, Deepaksan Tradex LLP, Urbasy (India) Apparels Private Limited and 5 more | Managing Director | 03 Aug 1990 | 36 Years 2 Months | Current |
| Satish Vasant Matkar | Director | 01 May 2007 | 19 Years 5 Months | Current |
| Sunil Parmanand Kewalramani | Director | 01 Sep 2009 | 17 Years 1 Months | Current |
Ownership and Shareholding of Medilux Laboratories Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medilux Laboratories Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2016 | Others | ₹75 Lakh | Open |
| 28 Nov 2016 | Others | ₹2.2 Cr | Open |
| 31 Aug 2016 | Others | ₹1.6 Cr | Open |
| 26 Jul 2016 | Others | ₹1.45 Cr | Open |
| 02 Sep 2015 | The Saraswat Co-Oprative Bank Limited | ₹2.4 Cr | Open |
Total charge records: 30 View all charges
Deals & Funding of Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd has 2 deals on record (2 funding rounds), with disclosed funding of ₹6.44 Cr; the latest was in February 2009.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2009 | Funding round | ₹2.43 Cr | Investors: 4 individuals |
| Jan 2009 | Funding round | ₹4.01 Cr | Investors: Modelite Holdings Private Limited, Kewalramani Finance & Inv Private Limited, Kay Dee Holding Co Private Limited, an individual |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd has 6 court cases on record: 1 filed by Medilux Laboratories, 5 filed against it. 2 cases are pending and 4 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 4 | 4 | 0 |
| NCLT | 1 | 1 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Indore | Court case (COMP.APPL) | Filed against the company by an individual | Pending |
| Bombay High Court | Writ petition | Filed by the company against Union of India | Pending |
| NCLAT, New Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| NCLAT, New Delhi | Company appeal | Filed against the company by an individual | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Medilux Laboratories Pvt Ltd
Medilux Laboratories operates one associated brand: Medilux. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing APIs and chemical intermediates for pharmaceutical applications. | medilux.co.in |
Employees and EPFO Compliance at Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd has a workforce of 373 employees as of Jul 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Medilux Laboratories Pvt Ltd
Medilux Laboratories has 2 subsidiary companies. This group structure data is as of FY 2018. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Medilux Healthcare Private Limited | U24232MP2011PTC026539 | Locked |
| Medilux Diagnostics Private Limited | U85195MP2011PTC026533 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity on Medilux Laboratories Pvt Ltd
Medilux Laboratories Pvt Ltd has 7 board changes on record since 1990: 4 appointments and 3 cessations. The latest: Pramod Ashtputra ceased to be Director on 06 May 2016.
41 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medilux Laboratories Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medilux Laboratories Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medilux Laboratories Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medilux Laboratories Pvt Ltd
Medilux Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCM1739L1ZI | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medilux Laboratories Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medilux Laboratories Pvt Ltd
Medilux Laboratories is an active private limited company based in Indore, Madhya Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 April 1985 (41+ years old) and is registered under CIN U24232MP1985PTC002843.
Medilux Laboratories reported revenue of ₹89.42 Cr for FY 2018 (down 2% YoY).
Medilux Laboratories has 4 current directors:
- Deepak Kanhiyalal Kewalramani - Managing Director
- Sanjay Kanhiyalal Kewalramani - Director
- Satish Vasant Matkar - Director
- Sunil Parmanand Kewalramani - Director
Medilux Laboratories reported a net profit of ₹7.71 Cr (net margin 8.6%) and EBITDA of ₹19.51 Cr (EBITDA margin 21.8%) for FY 2018, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medilux Laboratories is 14% over three years. In the latest year (FY 2018) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medilux Laboratories is 23AABCM1739L1ZI, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Medilux Laboratories is U24232MP1985PTC002843. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilux Laboratories has 6 court cases on record: 1 filed by the company and 5 filed against it. 2 are pending. Most are in the nclat.
Medilux Laboratories was incorporated on 25 April 1985, making it 41+ years old. It is registered with the Registrar of Companies, Gwalior.
Medilux Laboratories has 2 deals on record (2 funding rounds), with disclosed funding of ₹6.44 Cr; the latest was in February 2009.
The peers of Medilux Laboratories by revenue are Agog Pharma Limited, Alcedo Pharmachem Private Limited, Shrey Nutraceuticals and Herbals Private Limited, Verdant Life Sciences Private Limited, Sam Fine O Chem Limited and 5 more, all in the Pharma industry (API Manufacturers, Formulations).